A Single-Center Pilot Study to Assess Macular Function

Macular Degeneration Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01204541
• Other study ID #: 10-120-0013
• Status: Completed
• Phase: N/A
• First received: September 16, 2010
• Last updated: February 13, 2012
• Start date: September 2010
• Est. completion date: October 2010

Study information

• Verified date: February 2012
• Source: ORA, Inc.
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

This study seeks to evaluate a novel endpoint for future dry AMD clinical trials.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 24
• Est. completion date: October 2010
• Est. primary completion date: October 2010
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 20 Years to 90 Years

Eligibility

Inclusion Criteria:

• Subjects in good health aged 20-29 or 60-90 years (normal cohorts)

• Subjects with early non-exudative age-related macular degeneration (AMD cohort)

Exclusion Criteria:

• Enrollment in a investigational drug or device study and have used an investigational drug or device within 7 days of enrollment into this study

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Macular Degeneration

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
ORA, Inc.

Country where clinical trial is conducted

United States,